Q&A: The Why and How of Business Action

The role of the private sector in fighting HIV/AIDS, tuberculosis, and malaria has been evolving rapidly over the years. Indications are that businesses’ engagement is poised to produce even bigger results in the months and years ahead.

So Business Action asked a range of leaders in thought and action to tell us how they see business’ role, what the key components of success are, and what it will take to achieve the even-greater impact that is needed to turn the corner in the fight.

All Files below are in PDF format.

CEO Perspectives

John Anderson, CEO, Levi Strauss & Co.
Debra Lee, Chairman & CEO, BET Networks
Graham Mackay, CEO, SABMiller
Gilles Pélisson, CEO, Accor
Vimal Shah, CEO, Bidco Oil Company
Daniel Vasella, Chairman & CEO, Novartis
Andrew Wilty, CEO, GlaxoSmithKline

On-the-Ground Perspectives

Peris Waithera, HR Assistant, Bidco Oil Refineries
Gerishon Kariuki, Peer Educator, Phillips Pharmaceuticals (Power Technics)
Tina Meng, Administrative Manager, Anglo American
Eduard Gevorkyan, Medical Advisor, Shell
Josephine, Employee Living with HIV, Unilever
Thabo Baloyi, Contracts Administrator and Peer Educator, Living with HIV, Mercedes-Benz Financial Services South Africa (Pty) Ltd
Iris Wang, CSR Manager, GM China
Mandlenkosi Ngxama, Peer Educator, Manufacturing, Mercedes-Benz South Africa Pty Ltd
Ncedo Deleki, Peer Educator, Manufacturing, Mercedes-Benz South Africa Pty Ltd
Karien Liebenberg, Wellness Centre Manager, Mercedes-Benz South Africa - Shared Services

Partner Perspectives

Rajat Gupta, Chair of the Board, The Global Fund to Fight AIDS, Tuberculosis and Malaria
Dr. Peter Piot, Executive Director, UNAIDS
Ambassador Mark Dybul, U.S. Global AIDS Coordinator
Ray Chambers, UN Special Envoy on Malaria
Ellen Johnson-Sirleaf, President of Liberia

Thought-Leader Perspectives

Frank Brown, Dean, INSEAD
Brent Chrite, Leader of African business development intiatives
Stuart L. Hart, Base of the Pyramid and sustainability expert